Skip to main content
. 2022 Oct 6;13:1015128. doi: 10.3389/fimmu.2022.1015128

Figure 1.

Figure 1

The biological function of C1s, related diseases and its application in diagnosis and treatment. 1. Biological functions of C1s; 2. C1s related diseases; 3. Application of C1s as a target in disease diagnosis and treatment. AMD: age-related macular degeneration; AMR: antibody-mediated rejection; APOM: acute pneumococcal otitis media; BP: bullous pemphigoid; CAD: cold agglutinin disease; CDIP: chronic inflammatory demyelinating polyradiculoneuropathy; COVID-19, coronavirus disease 2019; cScc: cutaneous squamous cell carcinoma cells; C1INH: C1 esterase inhibitors; ELISA, enzyme-linked immunosorbent assay; ESRD: end-stage renal disease; SLE: systemic lupus erythematosus; HAE: hereditary angioedema; HCC: hepatocellular carcinoma; HMGB1:high-mobility group box 1; IGFBP5: insulin-like growth factor binding protein-5; ITP: idiopathic thrombocytopenic purpura; LRP: low-density lipoprotein receptor-related protein; MAC: membrane attacking complex; MHC1: Major histocompatibility complex 1; NCL: nucleolin; NGS, next-generation sequencing; NPM1: nucleophosmin 1; pEDS: periodontal ehlers-danlos syndrome; PNH: paroxysmal nocturnal haemoglobinuria; RA: rheumatoid arthritis; Rcc: renal cell carcinoma; ROM: recurrent otitis media; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; WAIHA: warm autoimmune hemolytic anemia.